Search: 4362 news

Open-access repository established to facilitate research on the disease holds anonymized data including clinical examinations and laboratory test results from 485,000 patients processed by five institutions.

Agricultural residues already produce 25% of the electricity used by households in the state. The proportion could jump to 70%, according to researchers who took part in an online seminar on the topic.

Study conducted at University of Campinas in collaboration with University of Michigan explains nanoscale physics of this manmade material in article published in Science Advances.

Researchers in Brazil, Argentina, Chile, and the UK are participating in the initiative. Results are published in the journal BioScience.

Study by researchers at the University of Campinas published in Physical Review Letters discusses both light dispersion by vibrations inside the device and light dissipation to the exterior, an aspect rarely studied hitherto.

The use of CAR T-cells reprogrammed to “recognize” Cryptococcus spp. proved effective to combat the infection in vitro and in mice.

There is no universally adopted system or standard for collecting, documenting and sharing the massive amount of data from research on the disease, noted an expert who took part in the Second Latin American and Caribbean Scientific Data Management Workshop.

In October the CDC recommended ten instead of 14 days of isolation for patients with mild or moderate symptoms, but Brazilian researchers found viable viral particles in 25% of samples collected from patients on the tenth day of symptoms.

Operating in the São José dos Campos Technology Park, Autaza’s RIC has an optical system for automotive paint quality inspection using computer vision and artificial intelligence.

The black and white tegu lizard, which depends on external environmental factors to regulate body temperature, can survive swings between 15 and 35 degrees Celsius in a single day while keeping blood pressure steady. This study extends scientists’ knowledge of cardiovascular regulation in vertebrates.

Scientists will monitor areas in which these diseases are endemic, such as São Paulo, the Amazon, the Pantanal and Panama, to investigate the factors that trigger outbreaks.

Researchers at the University of São Paulo estimated biodiversity and biomass losses in the biome using data from 1,819 forest inventories. In terms of carbon storage, the losses correspond to the destruction of 70,000 km² of forest, representing some USD 2.6 billion in carbon credits.

Researchers describe a scenario in which randomly distributed non-polarized metal “puddles” are immersed in a polarized insulating matrix.

With FAPESP’s support, PangeiaBiotech develops genetically modified varieties of sugarcane that are protected against attacking insects and glyphosate-tolerant.

Scientists who study capuchin monkeys on a nature reserve in Brazil found that stone tools are used for digging, seed pounding, and stone-on-stone percussion. The monkeys can serve as a model to help understand how humans evolved to use tools.

Startup supported by FAPESP has developed equipment for biological control of pests that affect soybean and cotton production.

In an article published in Scientific Reports, Brazilian researchers show that besides simplifying operational logistics and improving production, fertilization of the grass used as a cover crop can reduce fertilizer use in the long run.

The new Applied Research Center’s mission is to conduct research that can provide input for public policies. FAPESP is partnering with the Maria Cecilia Souto Vidigal Foundation and INSPER to mount the initiative.

An analysis conducted in the Brazilian state of São Paulo detected seven proteins in plasma from hospitalized patients that could be used in novel treatments and methods of identifying potentially severe or critical cases.

The different criteria used in Phase 3 clinical trials of the vaccines approved so far were explained by scientists in a webinar hosted by FAPESP. The impact of delays in vaccinating Brazilians was one of the topics discussed.

According to a paper by Brazilian researchers published in Nano Today, the spatial arrangement of proteins on the surface of SARS-CoV-2 assures highly efficient interaction with target receptors on human cells.

With FAPESP’s support, Hytron has developed a containerized solution for hydrogen production via ethanol reforming that eliminates the need for shipping by tanker trucks. The equipment can supply the gas to factories and vehicle service stations.

Filaments made of polymer-coated iron oxide nanoparticles are obtained by exposing the material to a magnetic field under controlled temperature. The applications are myriad and include transporting substances into cells or directing fluids.

Brazilian researchers used functional magnetic resonance imaging to assess 86 volunteers who had moderate COVID-19 and compared the results with those of uninfected volunteers. Preliminary findings have not yet been published but were presented during a conference held at the University of Campinas.

Clinical trial conducted in Brazil suggests the treatment can be beneficial if administered within ten days of symptom onset.

Study involving more than 200 hospitalized patients in São Paulo shows physically active individuals are not fully protected against the disease.

Fifty researchers at 26 institutions analyzed a huge mass of data, finding that no single size of conservation area is valid for the entire country.

A study by researchers at the University of São Paulo showed that the blood serum of severe patients contained high levels of the neurotransmitter acetylcholine and lipid mediators derived from arachidonic acid. The discovery may help improve the prognosis of such patients and the treatment available to them.

Brazilian researchers applied an examination protocol based on an analysis of 12 lung regions to 180 severe patients and found that the higher the lung ultrasound score the greater the risk of ICU admission, intubation and death.

Technology based on nanoparticles identifies IgG antibodies and costs only about a fifth of similar devices now on the market. It was developed by scientists at the University of São Paulo and Brazilian startup Biolinker.